Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire
===============================================================================================================================================================

* Ahmad Tarhini
* Yan Lin
* Huang Lin
* Zahra Rahman
* Priyanka Vallabhaneni
* Prateek Mendiratta
* James F. Pingpank
* Matthew P. Holtzman
* Erik C. Yusko
* Julie A. Rytlewski
* Uma N. M. Rao
* Robert L. Ferris
* John M. Kirkwood